# Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy

> **NCT05589974** · — · RECRUITING · sponsor: **Helse Stavanger HF** · enrollment: 50 (estimated)

## Conditions studied

- Central Serous Chorioretinopathy

## Interventions

- **DRUG:** Verteporfin

## Key facts

- **NCT ID:** NCT05589974
- **Lead sponsor:** Helse Stavanger HF
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05589974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05589974, "Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05589974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*